Authors:
Cayatte, AJ
Rupin, A
Oliver-Krasinski, J
Maitland, K
Sansilvestri-Morel, P
Boussard, MF
Wierzbicki, M
Verbeuren, TJ
Cohen, RA
Citation: Aj. Cayatte et al., S17834, a new inhibitor of cell adhesion and atherosclerosis that targets NADPH oxidase, ART THROM V, 21(10), 2001, pp. 1577-1584
Authors:
Paysant, J
Rupin, A
Simonet, S
Fabiani, JN
Verbeuren, TJ
Citation: J. Paysant et al., Comparison of the contractile responses of human coronary bypass grafts and monkey arteries to human urotensin-II, FUN CL PHAR, 15(4), 2001, pp. 227-231
Authors:
Cayatte, AJ
Du, Y
Oliver-Krasinski, J
Lavielle, G
Verbeuren, TJ
Cohen, RA
Citation: Aj. Cayatte et al., The thromboxane receptor antagonist S18886 but not aspirin inhibits atherogenesis in apo E-deficient mice - Evidence that eicosanoids other than thromboxane contribute to atherosclerosis, ART THROM V, 20(7), 2000, pp. 1724-1728
Authors:
Verbeuren, TJ
Bouskela, E
Cohen, RA
Vanhoutte, PM
Citation: Tj. Verbeuren et al., Regulation of adhesion molecules: A new target for the treatment of chronic venous insufficiency, MICROCIRCUL, 7(6), 2000, pp. S41-S48
Citation: A. Rupin et al., Long-lasting cyclic guanosine-3 ',5 '-monophosphate accumulation in the medium of cultured smooth muscle cells from atherosclerotic rabbit aortas in response to exogenous or endogenous nitric oxide, FUN CL PHAR, 14(5), 2000, pp. 453-459
Authors:
Behr-Roussel, D
Rupin, A
Sansilvestri-Morel, P
Fabiani, JN
Verbeuren, TJ
Citation: D. Behr-roussel et al., Histochemical evidence for inducible nitric oxide synthase in advanced butnon-ruptured human atherosclerotic carotid arteries, HISTOCHEM J, 32(1), 2000, pp. 41-51
Authors:
Vayssettes-Courchay, C
Ragonnet, C
Cordi, AA
Verbeuren, TJ
Citation: C. Vayssettes-courchay et al., In vivo analysis of adrenergic and serotoninergic constrictions of the rabbit saphenous vein, EUR J PHARM, 408(3), 2000, pp. 277-288
Authors:
Behr-Roussel, D
Rupin, A
Simonet, S
Fabiani, JN
Verbeuren, TJ
Citation: D. Behr-roussel et al., Urinary nitrate excretion in cholesterol-fed rabbits: effect of a chronic treatment by N-iminoethyl-L-lysine, a selective inhibitor of inducible nitric oxide synthase, EUR J PHARM, 388(3), 2000, pp. 275-279
Authors:
Behr-Roussel, D
Rupin, A
Simonet, S
Bonhomme, E
Coumailleau, S
Cordi, A
Serkiz, B
Fabiani, JN
Verbeuren, TJ
Citation: D. Behr-roussel et al., Effect of chronic treatment with the inducible nitric oxide synthase inhibitor N-iminoethyl-L-lysine or with L-arginine on progression of coronary and aortic atherosclerosis in hypercholesterolemic rabbits, CIRCULATION, 102(9), 2000, pp. 1033-1038
Authors:
Chardigny, CI
Van der Perre, K
Simonet, S
Descombes, JJ
Fabiani, JN
Verbeuren, TJ
Citation: Ci. Chardigny et al., Platelets and prostacyclin in arterial bypasses: Implications for coronaryartery surgery, ANN THORAC, 69(2), 2000, pp. 513-519
Authors:
Behr, D
Rupin, A
Fabiani, JN
Verbeuren, TJ
Citation: D. Behr et al., Distribution and prevalence of inducible nitric oxide synthase in atherosclerotic vessels of long-term cholesterol-fed rabbits, ATHEROSCLER, 142(2), 1999, pp. 335-344